COVID-19 Impact on Global Genital Herpes Treatment Drugs Market Size, Status and Forecast 2020-2026
- BMR3903694
- 95 Pages
- June 2020
- Healthcare
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Genital Herpes Treatment Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Genital Herpes Treatment Drugs industry.
Based on our recent survey, we have several different scenarios about the Genital Herpes Treatment Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Genital Herpes Treatment Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genital Herpes Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genital Herpes Treatment Drugs market in terms of revenue.
Players, stakeholders, and other participants in the global Genital Herpes Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Genital Herpes Treatment Drugs market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Genital Herpes Treatment Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genital Herpes Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genital Herpes Treatment Drugs market.
The following players are covered in this report:
AstraZeneca, Plc.
Apotheca, Inc.
Asahi Kasei Pharma Corporation
Carlsbad Technology, Inc.
GlaxoSmithkline, Plc.
Mylan N.V.
Novartis AG.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Zydus Pharmaceuticals, Inc.
Genital Herpes Treatment Drugs Breakdown Data by Type
Acyclovir
Famciclovir
Valacyclovir
Genital Herpes Treatment Drugs Breakdown Data by Application
Hospitals
Clinic
Others
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genital Herpes Treatment Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acyclovir
1.4.3 Famciclovir
1.4.4 Valacyclovir
1.5 Market by Application
1.5.1 Global Genital Herpes Treatment Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Genital Herpes Treatment Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Genital Herpes Treatment Drugs Industry
1.6.1.1 Genital Herpes Treatment Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Genital Herpes Treatment Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Genital Herpes Treatment Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Genital Herpes Treatment Drugs Market Perspective (2015-2026)
2.2 Genital Herpes Treatment Drugs Growth Trends by Regions
2.2.1 Genital Herpes Treatment Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genital Herpes Treatment Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Genital Herpes Treatment Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genital Herpes Treatment Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Genital Herpes Treatment Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Genital Herpes Treatment Drugs Players by Market Size
3.1.1 Global Top Genital Herpes Treatment Drugs Players by Revenue (2015-2020)
3.1.2 Global Genital Herpes Treatment Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Genital Herpes Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genital Herpes Treatment Drugs Market Concentration Ratio
3.2.1 Global Genital Herpes Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Drugs Revenue in 2019
3.3 Genital Herpes Treatment Drugs Key Players Head office and Area Served
3.4 Key Players Genital Herpes Treatment Drugs Product Solution and Service
3.5 Date of Enter into Genital Herpes Treatment Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Genital Herpes Treatment Drugs Historic Market Size by Type (2015-2020)
4.2 Global Genital Herpes Treatment Drugs Forecasted Market Size by Type (2021-2026)
5 Genital Herpes Treatment Drugs Breakdown Data by Application (2015-2026)
5.1 Global Genital Herpes Treatment Drugs Market Size by Application (2015-2020)
5.2 Global Genital Herpes Treatment Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genital Herpes Treatment Drugs Market Size (2015-2020)
6.2 Genital Herpes Treatment Drugs Key Players in North America (2019-2020)
6.3 North America Genital Herpes Treatment Drugs Market Size by Type (2015-2020)
6.4 North America Genital Herpes Treatment Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Genital Herpes Treatment Drugs Market Size (2015-2020)
7.2 Genital Herpes Treatment Drugs Key Players in Europe (2019-2020)
7.3 Europe Genital Herpes Treatment Drugs Market Size by Type (2015-2020)
7.4 Europe Genital Herpes Treatment Drugs Market Size by Application (2015-2020)
8 China
8.1 China Genital Herpes Treatment Drugs Market Size (2015-2020)
8.2 Genital Herpes Treatment Drugs Key Players in China (2019-2020)
8.3 China Genital Herpes Treatment Drugs Market Size by Type (2015-2020)
8.4 China Genital Herpes Treatment Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Genital Herpes Treatment Drugs Market Size (2015-2020)
9.2 Genital Herpes Treatment Drugs Key Players in Japan (2019-2020)
9.3 Japan Genital Herpes Treatment Drugs Market Size by Type (2015-2020)
9.4 Japan Genital Herpes Treatment Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Genital Herpes Treatment Drugs Market Size (2015-2020)
10.2 Genital Herpes Treatment Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genital Herpes Treatment Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Genital Herpes Treatment Drugs Market Size by Application (2015-2020)
11 India
11.1 India Genital Herpes Treatment Drugs Market Size (2015-2020)
11.2 Genital Herpes Treatment Drugs Key Players in India (2019-2020)
11.3 India Genital Herpes Treatment Drugs Market Size by Type (2015-2020)
11.4 India Genital Herpes Treatment Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Genital Herpes Treatment Drugs Market Size (2015-2020)
12.2 Genital Herpes Treatment Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Genital Herpes Treatment Drugs Market Size by Type (2015-2020)
12.4 Central & South America Genital Herpes Treatment Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca, Plc.
13.1.1 AstraZeneca, Plc. Company Details
13.1.2 AstraZeneca, Plc. Business Overview and Its Total Revenue
13.1.3 AstraZeneca, Plc. Genital Herpes Treatment Drugs Introduction
13.1.4 AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020))
13.1.5 AstraZeneca, Plc. Recent Development
13.2 Apotheca, Inc.
13.2.1 Apotheca, Inc. Company Details
13.2.2 Apotheca, Inc. Business Overview and Its Total Revenue
13.2.3 Apotheca, Inc. Genital Herpes Treatment Drugs Introduction
13.2.4 Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.2.5 Apotheca, Inc. Recent Development
13.3 Asahi Kasei Pharma Corporation
13.3.1 Asahi Kasei Pharma Corporation Company Details
13.3.2 Asahi Kasei Pharma Corporation Business Overview and Its Total Revenue
13.3.3 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Introduction
13.3.4 Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.3.5 Asahi Kasei Pharma Corporation Recent Development
13.4 Carlsbad Technology, Inc.
13.4.1 Carlsbad Technology, Inc. Company Details
13.4.2 Carlsbad Technology, Inc. Business Overview and Its Total Revenue
13.4.3 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Introduction
13.4.4 Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.4.5 Carlsbad Technology, Inc. Recent Development
13.5 GlaxoSmithkline, Plc.
13.5.1 GlaxoSmithkline, Plc. Company Details
13.5.2 GlaxoSmithkline, Plc. Business Overview and Its Total Revenue
13.5.3 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Introduction
13.5.4 GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.5.5 GlaxoSmithkline, Plc. Recent Development
13.6 Mylan N.V.
13.6.1 Mylan N.V. Company Details
13.6.2 Mylan N.V. Business Overview and Its Total Revenue
13.6.3 Mylan N.V. Genital Herpes Treatment Drugs Introduction
13.6.4 Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.6.5 Mylan N.V. Recent Development
13.7 Novartis AG.
13.7.1 Novartis AG. Company Details
13.7.2 Novartis AG. Business Overview and Its Total Revenue
13.7.3 Novartis AG. Genital Herpes Treatment Drugs Introduction
13.7.4 Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.7.5 Novartis AG. Recent Development
13.8 Merck & Co., Inc.
13.8.1 Merck & Co., Inc. Company Details
13.8.2 Merck & Co., Inc. Business Overview and Its Total Revenue
13.8.3 Merck & Co., Inc. Genital Herpes Treatment Drugs Introduction
13.8.4 Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.8.5 Merck & Co., Inc. Recent Development
13.9 Teva Pharmaceutical Industries Ltd.
13.9.1 Teva Pharmaceutical Industries Ltd. Company Details
13.9.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
13.9.3 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Introduction
13.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
13.10 Zydus Pharmaceuticals, Inc.
13.10.1 Zydus Pharmaceuticals, Inc. Company Details
13.10.2 Zydus Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.10.3 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Introduction
13.10.4 Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020)
13.10.5 Zydus Pharmaceuticals, Inc. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Genital Herpes Treatment Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Genital Herpes Treatment Drugs Revenue
Table 3. Ranking of Global Top Genital Herpes Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acyclovir
Table 6. Key Players of Famciclovir
Table 7. Key Players of Valacyclovir
Table 8. COVID-19 Impact Global Market: (Four Genital Herpes Treatment Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Genital Herpes Treatment Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Genital Herpes Treatment Drugs Players to Combat Covid-19 Impact
Table 13. Global Genital Herpes Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Genital Herpes Treatment Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Genital Herpes Treatment Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Genital Herpes Treatment Drugs Market Share by Regions (2015-2020)
Table 17. Global Genital Herpes Treatment Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Genital Herpes Treatment Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Genital Herpes Treatment Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Genital Herpes Treatment Drugs Players
Table 24. Global Genital Herpes Treatment Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Genital Herpes Treatment Drugs Market Share by Players (2015-2020)
Table 26. Global Top Genital Herpes Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genital Herpes Treatment Drugs as of 2019)
Table 27. Global Genital Herpes Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Genital Herpes Treatment Drugs Product Solution and Service
Table 30. Date of Enter into Genital Herpes Treatment Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Genital Herpes Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Genital Herpes Treatment Drugs Market Size Share by Type (2015-2020)
Table 34. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Genital Herpes Treatment Drugs Market Size Share by Application (2015-2020)
Table 36. Global Genital Herpes Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Genital Herpes Treatment Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Genital Herpes Treatment Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Genital Herpes Treatment Drugs Market Share (2019-2020)
Table 40. North America Genital Herpes Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Genital Herpes Treatment Drugs Market Share by Type (2015-2020)
Table 42. North America Genital Herpes Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Genital Herpes Treatment Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Genital Herpes Treatment Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Genital Herpes Treatment Drugs Market Share (2019-2020)
Table 46. Europe Genital Herpes Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Genital Herpes Treatment Drugs Market Share by Type (2015-2020)
Table 48. Europe Genital Herpes Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Genital Herpes Treatment Drugs Market Share by Application (2015-2020)
Table 50. China Key Players Genital Herpes Treatment Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players Genital Herpes Treatment Drugs Market Share (2019-2020)
Table 52. China Genital Herpes Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China Genital Herpes Treatment Drugs Market Share by Type (2015-2020)
Table 54. China Genital Herpes Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China Genital Herpes Treatment Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players Genital Herpes Treatment Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Genital Herpes Treatment Drugs Market Share (2019-2020)
Table 58. Japan Genital Herpes Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Genital Herpes Treatment Drugs Market Share by Type (2015-2020)
Table 60. Japan Genital Herpes Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Genital Herpes Treatment Drugs Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Genital Herpes Treatment Drugs Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Genital Herpes Treatment Drugs Market Share (2019-2020)
Table 64. Southeast Asia Genital Herpes Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Genital Herpes Treatment Drugs Market Share by Type (2015-2020)
Table 66. Southeast Asia Genital Herpes Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Genital Herpes Treatment Drugs Market Share by Application (2015-2020)
Table 68. India Key Players Genital Herpes Treatment Drugs Revenue (2019-2020) (Million US$)
Table 69. India Key Players Genital Herpes Treatment Drugs Market Share (2019-2020)
Table 70. India Genital Herpes Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. India Genital Herpes Treatment Drugs Market Share by Type (2015-2020)
Table 72. India Genital Herpes Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. India Genital Herpes Treatment Drugs Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Genital Herpes Treatment Drugs Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Genital Herpes Treatment Drugs Market Share (2019-2020)
Table 76. Central & South America Genital Herpes Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Genital Herpes Treatment Drugs Market Share by Type (2015-2020)
Table 78. Central & South America Genital Herpes Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Genital Herpes Treatment Drugs Market Share by Application (2015-2020)
Table 80. AstraZeneca, Plc. Company Details
Table 81. AstraZeneca, Plc. Business Overview
Table 82. AstraZeneca, Plc. Product
Table 83. AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 84. AstraZeneca, Plc. Recent Development
Table 85. Apotheca, Inc. Company Details
Table 86. Apotheca, Inc. Business Overview
Table 87. Apotheca, Inc. Product
Table 88. Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 89. Apotheca, Inc. Recent Development
Table 90. Asahi Kasei Pharma Corporation Company Details
Table 91. Asahi Kasei Pharma Corporation Business Overview
Table 92. Asahi Kasei Pharma Corporation Product
Table 93. Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 94. Asahi Kasei Pharma Corporation Recent Development
Table 95. Carlsbad Technology, Inc. Company Details
Table 96. Carlsbad Technology, Inc. Business Overview
Table 97. Carlsbad Technology, Inc. Product
Table 98. Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 99. Carlsbad Technology, Inc. Recent Development
Table 100. GlaxoSmithkline, Plc. Company Details
Table 101. GlaxoSmithkline, Plc. Business Overview
Table 102. GlaxoSmithkline, Plc. Product
Table 103. GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 104. GlaxoSmithkline, Plc. Recent Development
Table 105. Mylan N.V. Company Details
Table 106. Mylan N.V. Business Overview
Table 107. Mylan N.V. Product
Table 108. Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 109. Mylan N.V. Recent Development
Table 110. Novartis AG. Company Details
Table 111. Novartis AG. Business Overview
Table 112. Novartis AG. Product
Table 113. Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 114. Novartis AG. Recent Development
Table 115. Merck & Co., Inc. Business Overview
Table 116. Merck & Co., Inc. Product
Table 117. Merck & Co., Inc. Company Details
Table 118. Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 119. Merck & Co., Inc. Recent Development
Table 120. Teva Pharmaceutical Industries Ltd. Company Details
Table 121. Teva Pharmaceutical Industries Ltd. Business Overview
Table 122. Teva Pharmaceutical Industries Ltd. Product
Table 123. Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 124. Teva Pharmaceutical Industries Ltd. Recent Development
Table 125. Zydus Pharmaceuticals, Inc. Company Details
Table 126. Zydus Pharmaceuticals, Inc. Business Overview
Table 127. Zydus Pharmaceuticals, Inc. Product
Table 128. Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2015-2020) (Million US$)
Table 129. Zydus Pharmaceuticals, Inc. Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genital Herpes Treatment Drugs Market Share by Type: 2020 VS 2026
Figure 2. Acyclovir Features
Figure 3. Famciclovir Features
Figure 4. Valacyclovir Features
Figure 5. Global Genital Herpes Treatment Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Genital Herpes Treatment Drugs Report Years Considered
Figure 10. Global Genital Herpes Treatment Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Genital Herpes Treatment Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Genital Herpes Treatment Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Genital Herpes Treatment Drugs Market Share by Players in 2019
Figure 15. Global Top Genital Herpes Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genital Herpes Treatment Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Drugs Revenue in 2019
Figure 17. North America Genital Herpes Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Genital Herpes Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Genital Herpes Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Genital Herpes Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Genital Herpes Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Genital Herpes Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Genital Herpes Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. AstraZeneca, Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. AstraZeneca, Plc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 26. Apotheca, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Apotheca, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 28. Asahi Kasei Pharma Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Asahi Kasei Pharma Corporation Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 30. Carlsbad Technology, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Carlsbad Technology, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 32. GlaxoSmithkline, Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithkline, Plc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 34. Mylan N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Mylan N.V. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 36. Novartis AG. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novartis AG. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 38. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Merck & Co., Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 40. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 42. Zydus Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Zydus Pharmaceuticals, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
